{"entity":{"type":"insider","cik":"0001350091","url":"/insider/0001350091","json_url":"/insider/0001350091.json","name":"Myers W Todd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":21,"first":"2006-12-06","last":"2008-08-06","span_basis":"filed_date"},"name_variants":[{"name":"Myers W Todd","source":"filing","n_filings":21,"first_seen":"2006-12-06","last_seen":"2008-08-06"}],"transactions":[{"id":3719277,"accession":"0001350091-08-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-08-000016","line_url":"/filing/0001350091-08-000016#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":2.96,"price_display":"2.96","price_state":"stated","total_value":2311.76,"total_display":"2,311.76","total_whole":"2,312","shares_owned_after":25005.0,"shares_owned_after_display":"25,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-05","filed_date":"2008-08-06","scope":"insider"},{"id":2709000,"accession":"0001350091-08-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-08-000014","line_url":"/filing/0001350091-08-000014#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":1249.6,"total_display":"1,249.60","total_whole":"1,250","shares_owned_after":24223.0,"shares_owned_after_display":"24,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-07","filed_date":"2008-07-07","scope":"insider"},{"id":3423378,"accession":"0001350091-08-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-08-000012","line_url":"/filing/0001350091-08-000012#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":1054.35,"total_display":"1,054.35","total_whole":"1,054","shares_owned_after":23442.0,"shares_owned_after_display":"23,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-05","filed_date":"2008-06-06","scope":"insider"},{"id":4045491,"accession":"0001350091-08-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-08-000010","line_url":"/filing/0001350091-08-000010#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":1116.83,"total_display":"1,116.83","total_whole":"1,117","shares_owned_after":22660.0,"shares_owned_after_display":"22,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-05","filed_date":"2008-05-06","scope":"insider"},{"id":3217008,"accession":"0001350091-08-000008","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001350091-08-000008","line_url":"/filing/0001350091-08-000008","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":1.3345710627400769,"price_display":"1.33","price_state":"stated","total_value":1042.3,"total_display":"1,042.30","total_whole":"1,042","shares_owned_after":21879.0,"shares_owned_after_display":"21,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-07","filed_date":"2008-04-08","scope":"insider","n_lines":4},{"id":3776877,"accession":"0001350091-08-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-08-000006","line_url":"/filing/0001350091-08-000006#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":3163.05,"total_display":"3,163.05","total_whole":"3,163","shares_owned_after":21097.0,"shares_owned_after_display":"21,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-05","filed_date":"2008-03-05","scope":"insider"},{"id":2837680,"accession":"0001350091-08-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-08-000004","line_url":"/filing/0001350091-08-000004#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":3436.4,"total_display":"3,436.40","total_whole":"3,436","shares_owned_after":20316.0,"shares_owned_after_display":"20,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-05","filed_date":"2008-02-05","scope":"insider"},{"id":3464075,"accession":"0001350091-08-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-08-000002","line_url":"/filing/0001350091-08-000002#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":4022.15,"total_display":"4,022.15","total_whole":"4,022","shares_owned_after":19534.0,"shares_owned_after_display":"19,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-07","filed_date":"2008-01-07","scope":"insider"},{"id":7925659,"accession":"0001350091-07-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-07-000024","line_url":"/filing/0001350091-07-000024#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":3787.85,"total_display":"3,787.85","total_whole":"3,788","shares_owned_after":18753.0,"shares_owned_after_display":"18,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-05","filed_date":"2007-12-05","scope":"insider"},{"id":7042616,"accession":"0001350091-07-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-07-000022","line_url":"/filing/0001350091-07-000022#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":5076.5,"total_display":"5,076.50","total_whole":"5,077","shares_owned_after":17971.0,"shares_owned_after_display":"17,971","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-05","filed_date":"2007-11-05","scope":"insider"},{"id":7002547,"accession":"0001350091-07-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-07-000020","line_url":"/filing/0001350091-07-000020#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":6.2,"price_display":"6.20","price_state":"stated","total_value":4842.2,"total_display":"4,842.20","total_whole":"4,842","shares_owned_after":17190.0,"shares_owned_after_display":"17,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-05","filed_date":"2007-10-05","scope":"insider"},{"id":8160937,"accession":"0001350091-07-000018","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001350091-07-000018","line_url":"/filing/0001350091-07-000018","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":6.171702944942382,"price_display":"6.17","price_state":"stated","total_value":4820.1,"total_display":"4,820.10","total_whole":"4,820","shares_owned_after":16629.0,"shares_owned_after_display":"16,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-05","filed_date":"2007-09-05","scope":"insider","n_lines":3},{"id":7859632,"accession":"0001350091-07-000016","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001350091-07-000016","line_url":"/filing/0001350091-07-000016","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":6.667554417413572,"price_display":"6.67","price_state":"stated","total_value":5207.36,"total_display":"5,207.36","total_whole":"5,207","shares_owned_after":15808.0,"shares_owned_after_display":"15,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-06","filed_date":"2007-08-07","scope":"insider","n_lines":2},{"id":7193019,"accession":"0001350091-07-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-07-000014","line_url":"/filing/0001350091-07-000014#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":5.33,"price_display":"5.33","price_state":"stated","total_value":4162.73,"total_display":"4,162.73","total_whole":"4,163","shares_owned_after":14845.0,"shares_owned_after_display":"14,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-05","filed_date":"2007-07-09","scope":"insider"},{"id":7991189,"accession":"0001350091-07-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-07-000010","line_url":"/filing/0001350091-07-000010#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":4139.3,"total_display":"4,139.30","total_whole":"4,139","shares_owned_after":14064.0,"shares_owned_after_display":"14,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-05","filed_date":"2007-06-05","scope":"insider"},{"id":6935772,"accession":"0001350091-07-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001350091-07-000008","line_url":"/filing/0001350091-07-000008","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":5.028783610755442,"price_display":"5.03","price_state":"stated","total_value":3927.48,"total_display":"3,927.48","total_whole":"3,927","shares_owned_after":13563.0,"shares_owned_after_display":"13,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-07","filed_date":"2007-05-08","scope":"insider","n_lines":2},{"id":7092703,"accession":"0001350091-07-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-07-000007","line_url":"/filing/0001350091-07-000007#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":4.61,"price_display":"4.61","price_state":"stated","total_value":3600.41,"total_display":"3,600.41","total_whole":"3,600","shares_owned_after":12501.0,"shares_owned_after_display":"12,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-05","filed_date":"2007-04-05","scope":"insider"},{"id":7042613,"accession":"0001350091-07-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-07-000005","line_url":"/filing/0001350091-07-000005#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":3772.23,"total_display":"3,772.23","total_whole":"3,772","shares_owned_after":11719.0,"shares_owned_after_display":"11,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-05","filed_date":"2007-03-05","scope":"insider"},{"id":7489897,"accession":"0001350091-07-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-07-000004","line_url":"/filing/0001350091-07-000004#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":3045.9,"total_display":"3,045.90","total_whole":"3,046","shares_owned_after":10938.0,"shares_owned_after_display":"10,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-05","filed_date":"2007-02-05","scope":"insider"},{"id":7042610,"accession":"0001350091-07-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001350091-07-000002","line_url":"/filing/0001350091-07-000002","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":3.2096030729833545,"price_display":"3.21","price_state":"stated","total_value":2506.7,"total_display":"2,506.70","total_whole":"2,507","shares_owned_after":10306.0,"shares_owned_after_display":"10,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-01-05","filed_date":"2007-01-08","scope":"insider","n_lines":2},{"id":5293711,"accession":"0001350091-06-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001350091-06-000003","line_url":"/filing/0001350091-06-000003#line-2","is_derivative":false,"issuer_cik":"0001125603","issuer_name":"SGX PHARMACEUTICALS, INC.","issuer_ticker":"SGXP","issuer_name_source":null,"issuer_url":"/issuer/0001125603","owner_cik":"0001350091","owner_name":"Myers W Todd","owner_display_name":"Myers W Todd","owner_url":"/insider/0001350091","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9375.0,"shares_display":"9,375","price_per_share":2.99,"price_display":"2.99","price_state":"stated","total_value":28031.25,"total_display":"28,031.25","total_whole":"28,031","shares_owned_after":9375.0,"shares_owned_after_display":"9,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-05","filed_date":"2006-12-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001125603","name":"SGX PHARMACEUTICALS, INC.","url":"/issuer/0001125603","role":"Officer (CFO)","n_filings":21,"first_seen":"2006-12-06","last_seen":"2008-08-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001350091","retrieved_at":"2026-08-23T03:03:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}